Carr Douglas 4

What Happened Douglas Carr, Senior Vice President of Finance & Operations at Century Therapeutics (IPSC), reported the sale of 249 shares on 2026-06-08. The shares were sold at $2.11 each for a total proceeds of $526. This was a sale to cover tax withholding tied to restricted stock unit (RSU) vesting, not an active discretionary investment decision.

Key Details

• Transaction date and price: 2026-06-08, 249 shares at $2.11 per share (total $526).
• Transaction type/code: Sale (reported as S); sale described as done to cover tax withholding.
• Footnote: The sale was automatic to satisfy tax withholding obligations related to RSU vesting (footnote F1).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing timeliness: Report filed 2026-06-09 for a 2026-06-08 transaction — appears timely (within Form 4 reporting rules).

Context This was an automatic, mandatory sale to cover taxes upon RSU vesting — a common, routine insider transaction that typically does not signal a change in the insider’s view of the company. The dollar amount is small ($526), so the trade is unlikely to be material to investor sentiment on its own.